JPMorgan Chase & Co. Lowers Clorox (NYSE:CLX) Price Target to $150.00

Clorox (NYSE:CLX) had its price objective decreased by JPMorgan Chase & Co. from $158.00 to $150.00 in a research note issued to investors on Monday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

A number of other research firms have also weighed in on CLX. Deutsche Bank Aktiengesellschaft lowered their price objective on Clorox from $155.00 to $151.00 and set a hold rating on the stock in a research note on Wednesday, April 17th. UBS Group lowered their price objective on Clorox from $164.00 to $159.00 and set a neutral rating on the stock in a research note on Wednesday, May 1st. Morgan Stanley reissued an equal weight rating and set a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Jefferies Financial Group raised Clorox from an underperform rating to a hold rating and set a $145.00 price objective on the stock in a research note on Tuesday, March 26th. Finally, Evercore ISI lowered their price objective on Clorox from $145.00 to $142.00 and set an underperform rating on the stock in a research note on Wednesday, May 1st. Six research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. Based on data from MarketBeat.com, Clorox currently has a consensus rating of Hold and an average target price of $142.13.

Clorox Stock Performance

NYSE CLX opened at $133.35 on Monday. The company has a market cap of $16.56 billion, a PE ratio of 69.09, a price-to-earnings-growth ratio of 1.96 and a beta of 0.39. The stock’s 50 day simple moving average is $133.73 and its 200-day simple moving average is $142.70. Clorox has a 1-year low of $114.68 and a 1-year high of $169.14. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The business had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.51 earnings per share. As a group, equities research analysts anticipate that Clorox will post 5.92 EPS for the current fiscal year.

Institutional Investors Weigh In On Clorox

Institutional investors and hedge funds have recently modified their holdings of the company. Choreo LLC raised its holdings in shares of Clorox by 12.8% in the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after buying an additional 652 shares during the period. abrdn plc raised its holdings in shares of Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after buying an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. raised its holdings in shares of Clorox by 61.8% in the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after buying an additional 24,897 shares during the period. SG Americas Securities LLC raised its holdings in shares of Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after buying an additional 61,576 shares during the period. Finally, Mizuho Markets Americas LLC raised its holdings in shares of Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after buying an additional 34,864 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.